Medtronic plc has completed a private placement investment of 15,652,173 shares in Anteris Technologies Global Corp. at $5.75 per share, representing a $120 million commitment to support the development of the DurAVR® Transcatheter Heart Valve. This strategic investment supplements Anteris’ $200 million underwritten public offering and brings total capital raised to $320 million. Medtronic’s participation—structured through a wholly owned subsidiary—underscores its confidence in Anteris’ biomimetic valve technology and aligns with its broader objective to expand its portfolio in transcatheter aortic valve replacement. Wells Fargo Securities served as sole placement agent for Medtronic in the transaction.

In December 2025, Medtronic issued a voluntary removal of certain Left Heart Vent Catheter models after identifying that the devices may fail to maintain their designed malleable shape when bent, potentially compromising shaft positioning during cardiac procedures. Although no fatalities have been linked to the issue, Medtronic reported an unspecified number of malfunctions in which catheter distortion required additional intervention. The company has instructed customers to segregate impacted inventory and arrange returns, while the U.S. Food and Drug Administration continues to review the removal notice as a device safety communication.

Medtronic is on track to raise its quarterly dividend for the 48th straight year, extending its status as a Dividend Aristocrat. The company attributes this sustained payout growth to strong revenue contributions from its Pulsed Field Ablation platform and the Symplicity renal denervation franchise, both of which have seen double-digit unit growth over the last four quarters. Medtronic maintains an A credit rating from S&P Global Ratings with a stable outlook, reflecting its diversified product mix and disciplined balance-sheet management. Investors have been encouraged by management’s commitment to returning at least 50% of free cash flow through dividends and share repurchases in fiscal 2026.